2 completed, 1 active not recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Active not recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Malignant Ascites: new trials by email Literature Review of Malignant Ascites trials Research Report on Malignant Ascites
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody M701, paracentesis - Malignant Ascites | Phase 3 | Active not recruiting | Wuhan YZY Biopharma Co., Ltd. | 312 | 2024-03-25 | 2026-08-20 |
| CASIMAS: Catumaxomab Safety Phase IIIb Study With Intraperitoneal Infusion in Patients With Malignant Ascites Due to Epithelial Cancers Catumaxomab, Prednisolone - Cancer, Neoplasms | Phase 3 | Completed | Neovii Biotech | 230 | 2008-12-01 | 2012-10-03 |
| Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group Catumaxomab (Removab), paracentesis - EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast), Malignant Ascites | Phase 2 / Phase 3 | Completed | Neovii Biotech | 258 | 2004-09-01 | 2009-02-05 |
Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Paracentesis (2) · catumaxomab (2) · Prednisolone (1)
Neovii Biotech (2) · Wuhan YZY Biopharma Co., Ltd. (1)
China (1) · France (1) · Germany (1) · Italy (1) · Spain (1)
Florian Lordick, PD Dr. med. (1) · Jianming Xu, MD (1)